<sub>83</sub> Bi Bismuth‐Based Pharmaceuticals

Name: Work Video:
Duration: 3 min 30 s
Description: This chapter contains sections titled: Introduction Bismuth-Based Therapeutics Fundamental Aspects of Bismuth Chemistry and Methods of Characterization Hydroxycarboxylate Complexes of Bismuth Development of Bioactive Bismuth Compounds Interactions of Bismuth Compounds with Biological Molecules Concluding Remarks References
Neil Burford; Melanie D. Eelman
{'id': 'https://openalex.org/W1504474909', 'doi': 'https://doi.org/10.1002/0470864052.ch27', 'title': '<sub>83</sub> Bi Bismuth‐Based Pharmaceuticals', 'display_name': '<sub>83</sub> Bi Bismuth‐Based Pharmaceuticals', 'publication_year': 2005, 'publication_date': '2005-03-11', 'ids': {'openalex': 'https://openalex.org/W1504474909', 'doi': 'https://doi.org/10.1002/0470864052.ch27', 'mag': '1504474909'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1002/0470864052.ch27', 'pdf_url': None, 'source': None, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'other', 'type_crossref': 'other', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5052104109', 'display_name': 'Neil Burford', 'orcid': 'https://orcid.org/0000-0002-7698-390X'}, 'institutions': [{'id': 'https://openalex.org/I129902397', 'display_name': 'Dalhousie University', 'ror': 'https://ror.org/01e6qks80', 'country_code': 'CA', 'type': 'education', 'lineage': ['https://openalex.org/I129902397']}], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'Neil Burford', 'raw_affiliation_strings': ['Department of Chemistry, Dalhousie University, Halifax, Nova Scotia, B3H 4J3 (Canada)'], 'affiliations': [{'raw_affiliation_string': 'Department of Chemistry, Dalhousie University, Halifax, Nova Scotia, B3H 4J3 (Canada)', 'institution_ids': ['https://openalex.org/I129902397']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5057150193', 'display_name': 'Melanie D. Eelman', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I129902397', 'display_name': 'Dalhousie University', 'ror': 'https://ror.org/01e6qks80', 'country_code': 'CA', 'type': 'education', 'lineage': ['https://openalex.org/I129902397']}], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'Melanie D. Eelman', 'raw_affiliation_strings': ['Department of Chemistry, Dalhousie University, Halifax, Nova Scotia, B3H 4J3 (Canada)'], 'affiliations': [{'raw_affiliation_string': 'Department of Chemistry, Dalhousie University, Halifax, Nova Scotia, B3H 4J3 (Canada)', 'institution_ids': ['https://openalex.org/I129902397']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': None, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 2, 'citation_normalized_percentile': {'value': 0.795455, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 68, 'max': 71}, 'biblio': {'volume': None, 'issue': None, 'first_page': '529', 'last_page': '540'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11395', 'display_name': 'Radiopharmaceutical Chemistry and Applications', 'score': 0.9688, 'subfield': {'id': 'https://openalex.org/subfields/2741', 'display_name': 'Radiology, Nuclear Medicine and Imaging'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11395', 'display_name': 'Radiopharmaceutical Chemistry and Applications', 'score': 0.9688, 'subfield': {'id': 'https://openalex.org/subfields/2741', 'display_name': 'Radiology, Nuclear Medicine and Imaging'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/bismuth', 'display_name': 'Bismuth', 'score': 0.9907063}, {'id': 'https://openalex.org/keywords/characterization', 'display_name': 'Characterization', 'score': 0.46494144}], 'concepts': [{'id': 'https://openalex.org/C533668322', 'wikidata': 'https://www.wikidata.org/wiki/Q942', 'display_name': 'Bismuth', 'level': 2, 'score': 0.9907063}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.5173587}, {'id': 'https://openalex.org/C2780841128', 'wikidata': 'https://www.wikidata.org/wiki/Q5073781', 'display_name': 'Characterization (materials science)', 'level': 2, 'score': 0.46494144}, {'id': 'https://openalex.org/C171250308', 'wikidata': 'https://www.wikidata.org/wiki/Q11468', 'display_name': 'Nanotechnology', 'level': 1, 'score': 0.44317302}, {'id': 'https://openalex.org/C192562407', 'wikidata': 'https://www.wikidata.org/wiki/Q228736', 'display_name': 'Materials science', 'level': 0, 'score': 0.2770661}, {'id': 'https://openalex.org/C178790620', 'wikidata': 'https://www.wikidata.org/wiki/Q11351', 'display_name': 'Organic chemistry', 'level': 1, 'score': 0.21933639}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1002/0470864052.ch27', 'pdf_url': None, 'source': None, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W4387497383', 'https://openalex.org/W4229748205', 'https://openalex.org/W2948807893', 'https://openalex.org/W2778153218', 'https://openalex.org/W2748952813', 'https://openalex.org/W2527526854', 'https://openalex.org/W2062208111', 'https://openalex.org/W1986764834', 'https://openalex.org/W1976181487', 'https://openalex.org/W1531601525'], 'abstract_inverted_index': {'This': [0], 'chapter': [1], 'contains': [2], 'sections': [3], 'titled:': [4], 'Introduction': [5], 'Bismuth-Based': [6], 'Therapeutics': [7], 'Fundamental': [8], 'Aspects': [9], 'of': [10, 15, 19, 22, 27], 'Bismuth': [11, 20, 24, 28], 'Chemistry': [12], 'and': [13], 'Methods': [14], 'Characterization': [16], 'Hydroxycarboxylate': [17], 'Complexes': [18], 'Development': [21], 'Bioactive': [23], 'Compounds': [25, 29], 'Interactions': [26], 'with': [30], 'Biological': [31], 'Molecules': [32], 'Concluding': [33], 'Remarks': [34], 'References': [35]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W1504474909', 'counts_by_year': [{'year': 2020, 'cited_by_count': 1}], 'updated_date': '2024-12-09T13:53:05.080672', 'created_date': '2016-06-24'}
Publication Information

Basic Information

Access and Citation

AI Researcher Chatbot

Primary Location

Authors

Topics

Keywords

Related Works
